102 related articles for article (PubMed ID: 31090312)
1. [Current status and future prospect of pharmacotherapy for pancreatic cancer].
Fang Y; Lai MR; Ge YQ; Zhang GJ; Cheng RB
Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1509-1516. PubMed ID: 31090312
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacotherapy for pancreatic cancer: Difficulties and prospects].
Wang ZH; Zhou J; Shen L
Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):712-716. PubMed ID: 28926903
[TBL] [Abstract][Full Text] [Related]
3. Traditional Chinese medicine may be further explored as candidate drugs for pancreatic cancer: A review.
Gao Y; Chen S; Sun J; Su S; Yang D; Xiang L; Meng X
Phytother Res; 2021 Feb; 35(2):603-628. PubMed ID: 32965773
[TBL] [Abstract][Full Text] [Related]
4. Use of herbal medicines and natural products: an alternative approach to overcoming the apoptotic resistance of pancreatic cancer.
Li L; Leung PS
Int J Biochem Cell Biol; 2014 Aug; 53():224-36. PubMed ID: 24875648
[TBL] [Abstract][Full Text] [Related]
5. Combination treatment of advanced pancreatic cancer using novel vaccine and traditional therapies.
Matsui H; Hazama S; Shindo Y; Nagano H
Expert Rev Anticancer Ther; 2018 Dec; 18(12):1205-1217. PubMed ID: 30295097
[TBL] [Abstract][Full Text] [Related]
6. [Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas].
Bokemeyer C; Kollmannsberger C; Oettle H; Kanz L
Praxis (Bern 1994); 2000 Sep; 89(39):1545-52. PubMed ID: 11068508
[TBL] [Abstract][Full Text] [Related]
7. New therapeutic directions for advanced pancreatic cancer: cell cycle inhibitors, stromal modifiers and conjugated therapies.
Matera R; Saif MW
Expert Opin Emerg Drugs; 2017 Sep; 22(3):223-233. PubMed ID: 28783977
[TBL] [Abstract][Full Text] [Related]
8. [Personalized cancer medicine : Biomarkers for molecular therapy stratification in pancreatic carcinoma].
Ormanns S
Pathologe; 2018 Dec; 39(Suppl 2):221-224. PubMed ID: 30361776
[TBL] [Abstract][Full Text] [Related]
9. Complementary Chinese Herbal Medicine Therapy Improves Survival of Patients With Pancreatic Cancer in Taiwan: A Nationwide Population-Based Cohort Study.
Kuo YT; Liao HH; Chiang JH; Wu MY; Chen BC; Chang CM; Yeh MH; Chang TT; Sun MF; Yeh CC; Yen HR
Integr Cancer Ther; 2018 Jun; 17(2):411-422. PubMed ID: 28774207
[TBL] [Abstract][Full Text] [Related]
10. Status and future directions in the management of pancreatic cancer: potential impact of nanotechnology.
Sielaff CM; Mousa SA
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1205-1217. PubMed ID: 29721665
[TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
12. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pancreatic cancer: current limitations, future possibilities.
Blackstock AW; Cox AD; Tepper JE
Oncology (Williston Park); 1996 Mar; 10(3):301-7; discussion: 308-23. PubMed ID: 8820445
[TBL] [Abstract][Full Text] [Related]
14. Current and future biomarkers for pancreatic adenocarcinoma.
Loosen SH; Neumann UP; Trautwein C; Roderburg C; Luedde T
Tumour Biol; 2017 Jun; 39(6):1010428317692231. PubMed ID: 28618958
[TBL] [Abstract][Full Text] [Related]
15. A review of systemic therapy for advanced pancreatic cancer.
El-Rayes BF; Philip PA
Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
[TBL] [Abstract][Full Text] [Related]
16. Any second-line therapy for advanced pancreatic cancer? Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Li J; Merl MY; Saif MW
JOP; 2010 Mar; 11(2):151-3. PubMed ID: 20208325
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-gene signaling pathways in pancreatic cancer.
Drakaki A; Iliopoulos D
Biomed J; 2013; 36(5):200-8. PubMed ID: 24225187
[TBL] [Abstract][Full Text] [Related]
18. Emerging protein kinase inhibitors for treating pancreatic cancer.
Furuse J; Nagashima F
Expert Opin Emerg Drugs; 2017 Mar; 22(1):77-86. PubMed ID: 28253828
[TBL] [Abstract][Full Text] [Related]
19. Current status and future directions in the perioperative treatment of pancreatic cancer.
Wagener DJ; Punt CJ; Wilke H
Ann Oncol; 1994; 5 Suppl 3():87-90. PubMed ID: 8204535
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of pancreatic cancer. Actuality and perspective].
Bittoni A; Andrikou K; Lanese A; Santoni M; Pellei C; Faloppi L; Del Prete M; Giampieri R; Cascinu S
Recenti Prog Med; 2015 May; 106(5):208-16. PubMed ID: 25994537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
